Wednesday, September 12, 2012

Bacterin International Holdings, Inc. (BONE) Reports Positive First Clinical Results for OsteoSponge SC Product

Bacterin International Holdings develops, manufactures, and markets biologics products, such as bone graft material and antimicrobial coatings, worldwide. The company’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair, and dermal growth. These products are used in a wide variety of surgeries.

The company announced today that the first clinical results using the OsteoSponge SC product for regeneration of subchondral bone in complex lesions of the talus involving advanced subchondral bone damage have been published in the peer-reviewed journal, Foot & Ankle Specialist. The article reported on six month, post-operative outcomes on 7 patients which included pain and activity scales as well as radiographic findings. In each case, the patients reported a clinically significant reduction in pain and improvement in activity over the six month period. MRIs confirmed graft incorporation and restoration of an intact subchondral plate.

In addition, the company has begun a 75 patient registration for OsteoSponge SC, with the first patient enrolled in July, and has received approval to proceed in five of six sites so far. To date, OsteoSponge SC has been implanted in more than 250 patients and continues to produce excellent clinical results.

Bacterin estimates the current size of the market addressing subchondral defects in the foot, ankle, and knee to be approximately $1.7 billion annually. The market is expected to grow in future years as more advanced repair technologies become available. The company also believes that its OsteoSponge SC product may significantly change the standard of care globally for the treatment of damaged subchondral bone.

For additional information on Bacterin International Holdings, OsteoSponge SC, and the company’s other products, visit www.bacterin.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for "The QualityStocks Daily Newsletter" at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: